This prospective, surveillance study will assess the operational Zika virus definition for use in future Zika purified inactivated virus (ZIKV) vaccine efficacy trials in order to identify Zika virus disease (ZVD) cases among the study cohort.
This prospective, multicenter, cohort study will conduct active and passive surveillance for ZVD and determine its prevalence and seroconversion incidence in areas of Latin America experiencing Zika epidemic activity. A description of the occurrence of dengue virus and chikungunya virus infections in the cohort may also be provided as differential diagnosis of ZVD.
Study Type
OBSERVATIONAL
Enrollment
2,400
Investigational Site
Floridablanca, Santander Department, Colombia
Investigational Site
Cali, Valle del Cauca Department, Colombia
Investigational site
Tegucigalpa, Honduras
Investigational Site
Acapulco de Juárez, Guerrero, Mexico
Number of participants with suspected ZVD and virologically confirmed Zika (VCZ) infection in the cohort
Number of suspected ZVD and VCZ infections
Time frame: Day 0 to Day 365
Summary of the signs and symptoms accompanying suspected ZVD and VCZ cases in the study participants
Occurrence, intensity, and duration of signs and symptoms of ZVD and VCZ cases
Time frame: Day 0 to Day 365
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Investigational Site
Temixco, Morelos, Mexico
Investigational Site
Carolina, Puerto Rico